Dietrich (Rick) John Pauls

Executive

US·SEC (Form 4)

DiaMedica Therapeutics Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 10 Aug 2026 for DiaMedica Therapeutics Inc.. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Dietrich (Rick) John Pauls: trading record in brief

Dietrich (Rick) John Pauls appears in our data through filings on DiaMedica Therapeutics Inc. shares, published by SEC (Form 4). Over a trading history stretching from 1 December 2025 to 1 June 2026, the count stands at 2 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 10 August 2026 came the latest disclosure, an option exercise in DiaMedica Therapeutics Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.